Keywords: uPA; uPAR; PAI-1; Invasion; EMT; Metastasis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Eosinophilic esophagitis; eosinophilic oesophagitis; esophageal epithelium; epithelial differentiation; epithelial barrier; proteases; protease inhibitors; serine protease inhibitors; Kazal type; AD; Atopic dermatitis; ALI; Air-liquid interface; BMP; Bone
Keywords: ED; emergency department; ICU; intensive care unit; SOFA; sequential organ failure assessment; SIRS; systemic inflammatory response syndrome; CISS; Critical Illness and Shock Study; MEDS; mortality in emergency department sepsis; CCI; Charlson comorbidity
Keywords: A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
Keywords: Polymeric nanomedicines; Peptide; Cancer therapy; Therapeutic delivery; AF; aminoflavone; ANG; angiopep-2; BBB; blood brain barrier; BCECs; brain capillary endothelial cells; BP; bortezomib-pinanediol; bPEISS; bioreducible branched polyethylenimine; BPLP;
Keywords: uPAR; PET; Prostate cancer; Radionuclide imaging; Theranostics; Molecular imaging;
Keywords: VEGF; Vascular Endothelial Growth Factor; MMP; Matrixmetalloproteinases; uPAR; UrokinasePlasminogen Activator Receptor; Ang-1; Angiotensin-1; TGF-β; Transforming Growth Factor-β; VEGFR; Vascular Endothelial Growth Factor Receptor; TKI; Tyrosine Kinase I
Keywords: BVs; blood vessels; CSF; cerebrospinal fluid; ECM; extracellular matrix; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; GFAP; glial fibrillary acidic protein; IF; immunofluorescence; LV; lateral ventricle; MRI; magnetic resonance imaging; PBS; phosphate
Keywords: Systemic lupus erythematosus; Lupus nephritis; Podocytes; Lupus mice model; Immunosuppressive drugs; CD2AP; CD2-associated protein; TRPC; transient receptor potential canonical; IL; interleukin; TNFα; tumoral necrosis factor-alpha; IFNγ; interferon-gamm
Keywords: LIF; uPAR; Preeclampsia; Trophoblast; Invasion; PI3K/Akt
Keywords: Breast cancer; Necrosis; Apoptosis; Cytotoxicity; Cancer therapeutics; HMA; 5-(N,N-hexamethylene) amiloride; DCFH-DA; carboxy-2â²,7â²-dichloro-dihydro-fluorescein diacetate; ROS; reactive oxygen species; PI3K; phosphatidylinositol-3 kinase; PKB; protein
Keywords: uPA; urokinase-type plasminogen activator; uPAR; uPA receptor, all forms; uPAR(I-III); intact uPAR; uPAR(I); uPAR domain I; uPAR(II-III); cleaved uPAR domains II-III; TR-FIA; time-resolved fluorescence immunoassay; CRC; colorectal cancer; CV; coeffi
Keywords: ACR; American College of Rheumatology; ANA; antinuclear antibody; CHB; congenital heart block; CRP; C-reactive protein; GPI; glycosyl phosphatidylinositol; ECM; extracellular matrix; eGFR; estimated glomerular filtration; FSGS; focal segmental glomerulosc
Keywords: uPA; urokinase-type plasminogen activator; uPAR; urokinase-type plasminogen activator receptor; TR-FIA; time-resolved fluorescence immunoassays; OS; overall survival; PS; performance status; HR; hazard ratio; BID; bis in die = twice daily; Urokinase pla
Keywords: ADAM; (a disintegrin and metalloprotease) metallopeptidase; ALPs; alkyl-lysophospholipids; CD24; signal transducer CD24 (glycosylphosphatidylinositol-anchored receptor); CD44; CD44 antigen (receptor for hyaluronic acid); CXCR4; chemokine receptor type 4;
Keywords: PAI-1; plasminogen activator inhibitor-1; uPA; urokinase; tPA; tissue plasminogen activator; NF-κB; nuclear factor kappa-B; LPS; lipopolysaccharide; TNF; tumor necrosis factor; IL-1; interleukin-1; IL-6; interleukin-6; TLR4; toll-like receptor 4; ERK; ex
The mechanisms and clinical significance of PDCD4 in colorectal cancer
Keywords: Abbreviations; Full name in English; 3â²-UTR; 3â²-untranslated region; AA; asiatic acid; AOM; azoxymethane; AP-1; activating protein 1; AR; aldose reductase; ATF; activating transcription factor; Bcl-2; B-cell lymphoma 2; CAC; colitis-associated CRC; CD
Decreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury?
Keywords: Bipolar disorder; uPAR; Inflammation; Axonal regeneration;
Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins αMβ2 and αVβ3
Keywords: Plasminogen activation; Lipoprotein(a); uPAR; Atherothrombosis; Cardiovascular disease; Receptors;
Scutellaria: Debates on the anticancer property
Keywords: Bcl-2; B-cell lymphoma 2; 5-FU; 5-Fluorouracil; TGF-β1; transforming growth factor beta 1; PTEN; phosphatase and tensin homolog; HIF-1α; hypoxia-inducible factor 1-alpha; MAPK; mitogen-activated protein kinase; CRC; cyclic redundancy check; SHH; sonic h
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
Keywords: 15-LOX-1; 15-lipoxygenase; AIF; apoptosis inducing factor; APC; adenomatous polyposis coli; AKT or PKB; protein kinase B; ATG16L2; autophagy related 16 like 2; AUC; area under the curve; Bad; Bcl-2 associated death promoter; Bcl-2; B-cell lymphoma 2; Bcl-
Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer
Keywords: Multiplexed peptide conjugated nanoparticle; Wnt/LRP receptors; uPAR; Cancer stem cells; Chemo-resistant breast cancer;
Connexins, important players in the dissemination of prostate cancer cells
Keywords: AGA; alpha-glycyrrhetinic acid; ALP; alkaline phosphatase; BMEC; bone marrow endothelial cells; BPH; benign prostatic hyperplasia; Cbx; carbenoxolone; CSC; cancer stem cells; Cx; connexin; CXCL12; C-X-C motif chemokine 12; CXCR4; C-X-C chemokine receptor
UPAR targeted molecular imaging of cancers with small molecule-based probes
Keywords: Molecular imaging; Small molecule-based probes; UPAR; AE105; NIR-II; Multimodal imaging;
Preclinical uPAR-targeted multimodal imaging of locoregional oral cancer
Keywords: uPAR; urokinase-type plasminogen activator receptor; uPA; urokinase-type plasminogen activator; SPECT; single-photon emission computed tomography; PET; positron emission tomography; NIR; near infrared; FGS; fluorescent guided surgery; EGFR; epithelial gro
mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer
Keywords: mTORC2; Urokinase-type plasminogen activator; uPAR; Akt; Cell migration;
Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI3K/AKT, Wnt/β-catenin and NF-κB Signaling Pathways
Keywords: CDK; cyclin dependent kinase; COX; cyclooxygenase; ECM; extracellular matrix; EMT; epithelial-mesenchymal transition; GSK3β; glycogen synthase kinase 3 beta; ICAM; intercellular adhesion molecule; iNOS; inducible nitric oxide synthase; LY294002; (4-morph
Arterial endothelial cytokines guide extravillous trophoblast invasion towards spiral arteries; an in-vitro study with the trophoblast cell line ACH-3P and female non-uterine endothelial cells
Keywords: Placenta; Extravillous trophoblast; Invasion; Cytokines; Spiral arteries; AEC; arterial endothelial cells; Cdm; conditioned medium; EVT; extravillous trophoblast; IL; interleucin; uPAR; urokinase plasminogen activator receptor; VEC; venous endothelial cel
A Bifunctional Approach of Immunostimulation and uPAR Inhibition Shows Potent Antitumor Activity in Melanoma
Keywords: B-RAFi; B-RAF inhibition; ctrl; control; CXCL10; C-X-C motif chemokine 10; DR; acquired double resistance to B-RAFi and MEKi; MEKi; mitogen-activated protein kinase/extracellular signal-regulated kinase inhibition; OH; unmodified siRNA (hydroxy terminus);
Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies
Keywords: Biological Markers; Bone Marrow Neoplasms; Coagulation; Hematologic Neoplasms; uPAR;
Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallography
Keywords: uPAR; CD87; Epitope mapped antibodies; SPR; Allostery; Hot spots; Vitronectin; Cancer invasion
Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer
Keywords: uPAR; Large-cell lung cancer; Vasculogenic mimicry; Metastasis
Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder
Keywords: Bladder cancer; Urothelium; Prognosis; uPAR; Invasion;
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR
Keywords: mgp96; uPAR; Liver cancer; MAPK; DFS; ADAMTS9; a disintegrin-like and metalloprotease domain with thrombospondin type 1 motifs 9; AIMP1; aminoacyl tRNA synthetase complex-interacting multifunctional protein 1; AKT; v-akt murine thymoma viral oncogene homo
Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines
Keywords: ITGA6; Cancer; Actin; Focal adhesion kinase; Integrin linked kinase; uPAR
Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging
Keywords: uPAR; Urokinase; Dosimetry; PET; DOTA; Peptide; Translational;
Expression of urokinase type plasminogen activator receptor (uPAR) in the bovine oviduct: Relationship with uPA effect on oviductal epithelial cells
Keywords: uPAR; uPA; Oviduct; Culture; Bovine; c-fos
Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma
Keywords: NHL; non-Hodgkin's lymphoma; sLR11; soluble LDL receptor relative with 11 ligand-binding repeats; suPAR; soluble urokinase-type plasminogen activator receptor; sIL-2R; soluble interleukin-2 receptor; FL; follicular lymphoma; DLBCL; diffuse large B-cell ly
Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer
Keywords: AMP; adenosine monophosphate; ATP; adenosine triphosphate; BRCA1; breast cancer 1; BRCA2; breast cancer 2; eNAMPT; extracellular nicotinamide phosphoribosyltransferase; ERK; extracellular signal-regulated kinases; iNAMPT; intracellular nicotinamide phosph
TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression
Keywords: TGF-β; uPA; uPAR; EMT; cell invasion; retinal pigment epithelial cell; TGF-β; transforming growth factor-beta; EMT; epithelial-mesenchymal transition; uPA; urokinase-type plasminogen activator; uPAR; uPA receptor; RPE; retinal pigment epithelial; α-S
GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway
Keywords: EGF; GEP100; Arf6; ERK; uPAR; Invasion;
Small-molecule inhibition of the uPAR·uPA interaction: Synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis
Keywords: uPAR; urokinase receptor; uPA; urokinase-type plasminogen activator; suPAR; soluble urokinase receptor; uPAATF; amino terminal fragment of uPA; MMP; matrix metalloproteinase; FP; fluorescence polarization; NOD/SCID; non-obese diabetic severe combined immu
The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor
Keywords: 12-HHT; 12-hydroxy-5Z,8E,10E-heptadecatrienoic acid; 5,12-diHETE; 5S,12S-dihydroxy-6E,8Z,10E,14Z-eicosatetraenoic acid; 5,15-diHETE; 5S,15S-dihydroxy-6E,8Z,11Z,13E-eicosatetraenoic acid; 5-HEDH; 5-hydroxyeicosanoid dehydrogenase; 5-HEPE; 5S-hydroxy-6E,8Z,
First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts
Keywords: uPAR; PET 18F; Prostate cancer
Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study
Keywords: suPAR; Soluble urokinase plasminogen activator receptor; uPAR; Urokinase plasminogen activator receptor; HIV; Human Immunodeficiency Virus; CRP; C-reactive protein; PWV; Pulse wave velocity; SBP; Systolic blood pressure; DBP; Diastolic blood pressure; Cwk
Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma
Keywords: HNSCC, head and neck squamous cell carcinoma; EGFR, epidermal growth factor receptor; uPAR, urokinase-type plasminogen activator receptor; ATF, amino terminal fragment; TT, targeted toxinsEGFR; uPAR; ATF; Head and neck cancer; Breast cancer; Xenograft mod
Glycosylation of prostate specific antigen and its potential diagnostic applications
Keywords: 2-DE; two-dimensional electrophoresis; AA(A); Aleuria aurantia agglutinin; AMACR; α-methylacyl-CoA racemase; BPH; benign prostatic hyperplasia; BPSA; benign prostatic hyperplasia associated PSA; Con A; Concanavalin A; CE; capillary electrophoresis; ELLA;
Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias
Keywords: LR11/SorLA; Monocyte; AML; ALL; CD87; uPAR;
Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α
Keywords: VEGF; endothelial permeability; p38 MAP kinase; beta-catenin; uPAR
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts
Keywords: uPAR; PRRT; in vivo; 177Lu; Imaging;